Breakthrough Moments: Genome Editing and Organoids.
Published
Journal Article
Six years ago, Schwank et al. (2013) adapted CRISPR-Cas9 and organoid technology to repair genetic diseases in patient-derived tissues. We shine a spotlight on how this work has inspired the development of tools to study and correct genetic diseases in experimental systems, with the ultimate goal of treating human disease.
Full Text
Duke Authors
Cited Authors
- Roper, J; Yilmaz, ÖH
Published Date
- June 6, 2019
Published In
Volume / Issue
- 24 / 6
Start / End Page
- 841 - 842
PubMed ID
- 31173713
Pubmed Central ID
- 31173713
Electronic International Standard Serial Number (EISSN)
- 1875-9777
Digital Object Identifier (DOI)
- 10.1016/j.stem.2019.05.008
Language
- eng
Conference Location
- United States